Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone changes in thyrotoxicosis]

E Ejima1, K Fujiyama, T Kiriyama

  • 1First Department of Internal Medicine, Nagasaki University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cultured oncogenic osteomalacia tumor cells produce a factor(s) that inhibits osteocalcin production by osteoblastic cells.

Oncology reports·2011
Same author

Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.

Scandinavian journal of rheumatology·2006
Same author

Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency.

Gut·2003
Same author

Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.

Thyroid : official journal of the American Thyroid Association·2002
Same author

Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.

Clinical and experimental immunology·2001
Same author

Pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura.

Internal medicine (Tokyo, Japan)·2001
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Thyroid hormone (T3) impacts bone metabolism, stimulating both formation and resorption. Managing T3 levels is crucial for preventing bone loss, especially in postmenopausal women.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolic Disorders

Context:

  • Thyroid hormone (T3) plays a critical role in regulating bone metabolism.
  • Thyrotoxicosis, a condition of excess thyroid hormone, leads to accelerated bone turnover and potential bone loss.
  • Thyroid hormone replacement and TSH suppression therapies require careful monitoring to mitigate skeletal effects.

Purpose:

  • To elucidate the dual role of thyroid hormone in bone formation and resorption.
  • To highlight the consequences of thyrotoxicosis on bone mineral content.
  • To emphasize the importance of monitoring thyroid hormone levels and TSH in patients undergoing thyroid-related therapies.

Summary:

  • Thyroid hormone (T3) directly stimulates osteoblasts for bone formation and indirectly promotes osteoclast-mediated bone resorption.

Related Experiment Videos

  • Accelerated bone turnover in thyrotoxicosis results in significant bone loss, reflected by elevated bone metabolic markers.
  • Restoring normal thyroid hormone levels can partially reverse bone mineral deficits, but vigilant monitoring is essential.

    • Impact:

    • Informs clinical practice regarding the management of thyroid disorders and bone health.
    • Underscores the need for assessing bone mineral content in at-risk populations, including postmenopausal women.
    • Provides insights into the mechanisms underlying thyroid hormone's influence on skeletal homeostasis.